Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yinhua Miyanling Tablet for bacterial biofilm formation on ureteral stents
ChiCTR2000041399Phase 4Recruiting
- Sponsor
- Beijing Tongren Hospital
- Start
- Apr 2019
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Yinhua Miyanling in Lithiasis, urinary tract infection (UTI) and Bacterial biofilm (2 arms), sponsored by Beijing Tongren Hospital. Primary endpoints: Blood routine, Blood chemistry and 3 more. Started Apr 2019; status: recruiting.
02
Drugs
Yinhua Miyanling
03
Conditions
Lithiasisurinary tract infection (UTI)Bacterial biofilm
Beyond the preview
Go deeper on ChiCTR2000041399.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000041399.